Juno Therapeutics, Inc. v. Kite Pharma, Inc.
Petition for certiorari denied on November 7, 2022
Issue: Whether the adequacy of the "written description of [an] invention" is measured by the statutory standard of "in such full, clear, concise, and exact terms as to enable any person skilled in the art to make and use the same" in 35 U.S.C. " 112(a), or by the Federal Circuit"s test that the "written description of the invention" must demonstrate the inventor"s "possession" of "the full scope of the claimed invention" including all "known and unknown" variations of each component.
SCOTUSblog Coverage
- Intellectual property and Navajo water rights (John Elwood, November 2, 2022)
- What constitutes identity theft? (John Elwood, October 26, 2022)
- Reschedule Watch: Birthright citizenship and torts to members of the armed forces (John Elwood, October 13, 2022)
- The first relists of October Term 2022 (John Elwood, October 4, 2022)